AmirAli Talasaz, Director, Co-Chief Executive Officer, on May 20, 2026, sold 210,000 shares in Guardant Health (GH) for $23,076,690. Following the Form 4 filing with the SEC, Talasaz has control over a total of 1,886,504 common shares of the company, with 1,886,504 controlled indirectly.
SEC Filing:
Brian C White, Director, on May 20, 2026, sold 3,250 shares in Formfactor (FORM) for $409,500. Following the Form 4 filing with the SEC, White has control over a total of 8,653 common shares of the company, with 8,653 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1039399/000162828026037432/xslF345X05/wk-form4_1779400277.xml
Larry Robbins, Director, on May 19, 2026, sold 3,372,000 shares in CVS Health (CVS) for $317,471,136. Following the Form 4 filing with the SEC, Robbins has control over a total of 4,824,799 common shares of the company, with 4,824,799 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/64803/000090514826002617/xslF345X05/form4.xml
Scott L Beiser, 10% Owner, Director, Co-Chairman, on May 21, 2026, sold 6,265 shares in Houlihan Lokey (HLI) for $941,379.SEC Filing:https://www.sec.gov/Archives/edgar/data/1302215/000130221526000042/xslF345X05/wk-form4_1779399829.xml